# Point-of-Care Ultrasound Diagnosis of Emphysematous Cholecystitis

**Authors:** Helena L Kons, Ariana Gorman, Maxwell Thompson, Katherine Griesmer, Samuel L Burleson, David C Pigott, John P Gullett, Luke R Bishop

PMC · DOI: 10.7759/cureus.104248 · Cureus · 2026-02-25

## TL;DR

This paper shows how point-of-care ultrasound can quickly diagnose emphysematous cholecystitis, a serious gallbladder infection, in emergency settings.

## Contribution

The paper demonstrates the utility of POCUS as a rapid diagnostic tool for emphysematous cholecystitis in the emergency department.

## Key findings

- POCUS can detect intramural or intraluminal gallbladder gas in EC patients.
- Using POCUS can reduce diagnostic delays and expedite treatment in the ED.
- Early diagnosis with POCUS may lower the risk of gallbladder perforation and mortality.

## Abstract

Emphysematous cholecystitis (EC) is a form of cholecystitis characterized by the presence of intramural or intraluminal gallbladder gas secondary to infection by gas-forming bacteriaand is considered a surgical emergency. Computed tomography (CT) is considered the gold standard for the diagnosis of EC, but it can result in increased time to diagnosis and may not be readily available in the emergency department (ED). This delay in diagnosis may contribute to increased rates of gallbladder perforation and associated mortality. As emergency medicine door-to-first-provider times continue to increase, point-of-care ultrasonography (POCUS) can facilitate the diagnosis of this serious condition and expedite definitive care. We present a patient with EC diagnosed using POCUS and highlight the utility of POCUS in the evaluation and management of patients with this rare but serious condition. Therefore, early diagnosis and intervention are critical in the management of patients with EC, and POCUS may play an important role in the rapid diagnosis and definitive care of these patients in the ED setting.

## Linked entities

- **Diseases:** emphysematous cholecystitis (MONDO:0005742), cholecystitis (MONDO:0002155)

## Full-text entities

- **Diseases:** cholecystitis (MESH:D002764), chronic obstructive pulmonary disease (MESH:D029424), chronic kidney disease (MESH:D051436), anorexia (MESH:D000855), Abdominal pain (MESH:D015746), gallstones (MESH:D042882), diabetes (MESH:D003920), acute cholecystitis (MESH:D041881), pain (MESH:D010146), GB (MESH:D005705), peripheral vascular disease (MESH:D016491), inflammatory (MESH:D007249), EC (MESH:D041882), gangrene (MESH:D005734), tenderness (MESH:D063806), coronary artery disease (MESH:D003324), perforation (MESH:D057112), congestive heart failure (MESH:D006333), nausea, vomiting (MESH:D020250), leukocytosis (MESH:D007964), infection (MESH:D007239), lab abnormalities (MESH:D000014)
- **Chemicals:** bilirubin (MESH:D001663), oxygen (MESH:D010100), piperacillin/tazobactam (MESH:D000077725)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Clostridium perfringens (species) [taxon 1502], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935390/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935390/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935390/full.md

---
Source: https://tomesphere.com/paper/PMC12935390